Pharmaceutical firms see their cash reserves shrinking

A growing number of pharmaceutical manufacturing firms in Korea are struggling to stabilize their cash flow in the midst of falling operating profits due to massive cut prices earlier this year, data show Wednesday.

The current ratio at 57 listed companies reached 199 percent on average as of the end of June this year, down 8 percent from December of 2011, according to Yakup.com, a pharmaceu...